Acorda Therapeutics, Inc.
ACOR · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$27 | -$218 | -$9 | -$9 |
| Dep. & Amort. | $1 | $8 | $8 | $8 |
| Deferred Tax | $0 | -$38 | -$1 | -$2 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$5 | -$9 | $10 | -$12 |
| Other Non-Cash | $12 | $254 | -$0 | $4 |
| Operating Cash Flow | -$20 | -$3 | $8 | -$12 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$0 | -$0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $7 | $0 | $0 |
| Financing Cash Flow | $0 | $7 | -$7 | $0 |
| Forex Effect | -$0 | $0 | -$0 | $0 |
| Net Chg. in Cash | -$20 | -$3 | $7 | -$11 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $31 | $33 | $26 | $38 |
| End Cash | $10 | $30 | $34 | $26 |
| Free Cash Flow | -$20 | -$3 | $7 | -$12 |